{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T07:29:33Z","timestamp":1768548573654,"version":"3.49.0"},"posted":{"date-parts":[[2021,1,4]]},"group-title":"Infectious Diseases (except HIV\/AIDS)","reference-count":41,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2021,1,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Children are less clinically affected by SARS-CoV-2 infection than adults with the majority of cases being mild or asymptomatic and the differences in infection outcomes are poorly understood. The kinetics, magnitude and landscape of the antibody response may impact the clinical severity and serological diagnosis of COVID-19. Thus, a comprehensive investigation of the antibody landscape in children and adults is needed.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We tested 254 plasma from 122 children with symptomatic and asymptomatic SARS-CoV-2 infections in Hong Kong up to 206 days post symptom onset, including 146 longitudinal samples from 58 children. Adult COVID-19 patients and pre-pandemic controls were included for comparison. We assessed antibodies to a 14-wide panel of SARS-CoV-2 structural and accessory proteins by Luciferase Immunoprecipitation System (LIPS).<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Findings<\/jats:title>\n                  <jats:p>Children have lower levels of Spike and Nucleocapsid antibodies than adults, and their cumulative humoral response is more expanded to accessory proteins (NSP1 and Open Reading Frames (ORFs)). Sensitive serology using the three N, ORF3b, ORF8 antibodies can discriminate COVID-19 in children. Principal component analysis revealed distinct serological signatures in children and the highest contribution to variance were responses to non-structural proteins ORF3b, NSP1, ORF7a and ORF8. Longitudinal sampling revealed maintenance or increase of antibodies for at least 6 months, except for ORF7b antibodies which showed decline. It was interesting to note that children have higher antibody responses towards known IFN antagonists: ORF3b, ORF6 and ORF7a. The diversified SARS-CoV-2 antibody response in children may be an important factor in driving control of SARS-CoV-2 infection.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2021.01.03.21249180","type":"posted-content","created":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T13:50:18Z","timestamp":1609768218000},"source":"Crossref","is-referenced-by-count":12,"title":["The SARS-CoV-2 antibody landscape is lower in magnitude for structural proteins, diversified for accessory proteins and stable long-term in children"],"prefix":"10.64898","author":[{"given":"Asmaa","family":"Hachim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haogao","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Otared","family":"Kavian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mike YW","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wai-hung","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yat Sun","family":"Yau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan S","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Owen TY","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David SC","family":"Hui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fionn","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6688-9637","authenticated-orcid":false,"given":"Eric HY","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel MS","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leo LM","family":"Poon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JS Malik","family":"Peiris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie A","family":"Valkenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niloufar","family":"Kavian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2021010611101385000_2021.01.03.21249180v2.1","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.immuni.2020.05.002","article-title":"Immunology of COVID-19: Current State of the Science","volume":"52","year":"2020","journal-title":"Immunity"},{"key":"2021010611101385000_2021.01.03.21249180v2.2","doi-asserted-by":"crossref","unstructured":"Jones T.C., M.B. , Veith T. , Guido Biele , Marta Zuchowski , J\u00f6rg Hoffmann , Angela Stein , Anke Edelmann , Victor Max Corman, Christian Drosten. An analysis of SARS-CoV-2 viral load by patient age. medRxiv (2020).","DOI":"10.1101\/2020.06.08.20125484"},{"key":"2021010611101385000_2021.01.03.21249180v2.3","unstructured":"Valverde, I. , et al. Acute Cardiovascular Manifestations in 286 Children with Multisystem Inflammatory Syndrome Associated with COVID-19 Infection in Europe. Circulation (2020)."},{"key":"2021010611101385000_2021.01.03.21249180v2.4","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30198-5"},{"key":"2021010611101385000_2021.01.03.21249180v2.5","doi-asserted-by":"crossref","unstructured":"Zimmermann, P. & Curtis, N. Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections. Arch Dis Child (2020).","DOI":"10.1136\/archdischild-2020-320338"},{"key":"2021010611101385000_2021.01.03.21249180v2.6","doi-asserted-by":"crossref","first-page":"5703","DOI":"10.1038\/s41467-020-19545-8","article-title":"Immune responses to SARS-CoV-2 in three children of parents with symptomatic COVID-19","volume":"11","year":"2020","journal-title":"Nat Commun"},{"key":"2021010611101385000_2021.01.03.21249180v2.7","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25715"},{"key":"2021010611101385000_2021.01.03.21249180v2.8","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.3389\/fimmu.2020.01518","article-title":"Targeting the NLRP3 Inflammasome in Severe COVID-19","volume":"11","year":"2020","journal-title":"Front Immunol"},{"key":"2021010611101385000_2021.01.03.21249180v2.9","unstructured":"Bastard, P. , et al. Autoantibodies against type I IFNs in patients with life- threatening COVID-19. Science 370(2020)."},{"key":"2021010611101385000_2021.01.03.21249180v2.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.04.042"},{"key":"2021010611101385000_2021.01.03.21249180v2.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2007617"},{"key":"2021010611101385000_2021.01.03.21249180v2.12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.2648"},{"key":"2021010611101385000_2021.01.03.21249180v2.13","doi-asserted-by":"crossref","first-page":"e0237828","DOI":"10.1371\/journal.pone.0237828","article-title":"Performance of nucleocapsid and spike-based SARS-CoV-2 serologic assays","volume":"15","year":"2020","journal-title":"PLoS One"},{"key":"2021010611101385000_2021.01.03.21249180v2.14","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/s41590-020-0773-7","article-title":"ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection","volume":"21","year":"2020","journal-title":"Nat Immunol"},{"key":"2021010611101385000_2021.01.03.21249180v2.15","doi-asserted-by":"crossref","unstructured":"Martin-Sancho, L. , et al. Functional Landscape of SARS-CoV-2 Cellular Restriction. bioRxiv (2020).","DOI":"10.1101\/2020.09.29.319566"},{"key":"2021010611101385000_2021.01.03.21249180v2.16","doi-asserted-by":"crossref","first-page":"108185","DOI":"10.1016\/j.celrep.2020.108185","article-title":"SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant","volume":"32","year":"2020","journal-title":"Cell Rep"},{"key":"2021010611101385000_2021.01.03.21249180v2.17","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1080\/22221751.2020.1780953","article-title":"SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists","volume":"9","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"2021010611101385000_2021.01.03.21249180v2.18","unstructured":"Weisberg, S.P. , et al. Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum. Nat Immunol (2020)."},{"key":"2021010611101385000_2021.01.03.21249180v2.19","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.3389\/fmicb.2020.02086","article-title":"Is There a Link Between the Pathogenic Human Coronavirus Envelope Protein and Immunopathology? A Review of the Literature","volume":"11","year":"2020","journal-title":"Front Microbiol"},{"key":"2021010611101385000_2021.01.03.21249180v2.20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41590-020-00826-9","article-title":"Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum","volume":"22","year":"2021","journal-title":"Nat Immunol"},{"key":"2021010611101385000_2021.01.03.21249180v2.21","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa161"},{"key":"2021010611101385000_2021.01.03.21249180v2.22","unstructured":"Shrock, E. , et al. Viral epitope profiling of COVID-19 patients reveals cross- reactivity and correlates of severity. Science 370(2020)."},{"key":"2021010611101385000_2021.01.03.21249180v2.23","unstructured":"Ng, K.W. , et al. Preexisting and de novo humoral immunity to SARS-CoV-2 in humans. Science (2020)."},{"key":"2021010611101385000_2021.01.03.21249180v2.24","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/s41591-020-1083-1","article-title":"Seasonal coronavirus protective immunity is short-lasting","volume":"26","year":"2020","journal-title":"Nat Med"},{"key":"2021010611101385000_2021.01.03.21249180v2.25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/22221751.2020.1719902","article-title":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan","volume":"9","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"2021010611101385000_2021.01.03.21249180v2.26","doi-asserted-by":"crossref","unstructured":"Haddad Natalie S, N.D.C. , Kuruvilla Merin E , Morrison-Porter Andrea , Fabliha Anam , Kevin S Cashman , Richard P Ramonell , Shuya Kyu , Ankur Singh Saini , Monica Cabrera-Mora , Andrew Derrico , David Alter , John D Roback , Michael Horwath , James B O\u2019Keefe , Henry M Wu , An-Kwok Ian Wong , Alexandra W Dretler , Ria Gripaldo , Andrea N Lane , Hao Wu , Saeyun Lee , Mindy Hernandez , Vanessa Engineer , John Varghese , Sang Le , I\u00f1aki Sanz , John L Daiss , F Eun-Hyung Lee . Elevated SARS-CoV-2 Antibodies Distinguish Severe Disease in Early COVID-19 Infection. bioRxiv (2020).","DOI":"10.1101\/2020.12.04.410589"},{"key":"2021010611101385000_2021.01.03.21249180v2.27","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan6836"},{"key":"2021010611101385000_2021.01.03.21249180v2.28","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf4860"},{"key":"2021010611101385000_2021.01.03.21249180v2.29","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2550-z"},{"key":"2021010611101385000_2021.01.03.21249180v2.30","doi-asserted-by":"crossref","unstructured":"Galani, I.E. , et al. Untuned antiviral immunity in COVID-19 revealed by temporal type I\/III interferon patterns and flu comparison. Nat Immunol (2020).","DOI":"10.1101\/2020.08.21.20179291"},{"key":"2021010611101385000_2021.01.03.21249180v2.31","doi-asserted-by":"crossref","unstructured":"Wang, E.Y. , Mao, T. , Klein, J. , Dai, Y. , Huck, J. D. , Liu, F. , Zheng, N. S. , Ting Zhou , Benjamin Israelow , Patrick Wong , Carolina Lucas , Julio Silva ,, et al. Diverse Functional Autoantibodies in Patients with COVID-19. MedRXiv (2020).","DOI":"10.1101\/2020.12.10.20247205"},{"key":"2021010611101385000_2021.01.03.21249180v2.32","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3389\/fendo.2020.00476","article-title":"Increasing Co-occurrence of Additional Autoimmune Disorders at Diabetes Type 1 Onset Among Children and Adolescents Diagnosed in Years 2010-2018-Single-Center Study","volume":"11","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2021010611101385000_2021.01.03.21249180v2.33","doi-asserted-by":"crossref","unstructured":"Rodda, L.B. , et al. Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19. Cell (2020).","DOI":"10.1016\/j.cell.2020.11.029"},{"key":"2021010611101385000_2021.01.03.21249180v2.34","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0140-6736(20)31757-8","article-title":"Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"2021010611101385000_2021.01.03.21249180v2.35","doi-asserted-by":"crossref","unstructured":"Lam, J.Y. , et al. Loss of orf3b in the circulating SARS-CoV-2 strains. Emerg Microbes Infect, 1\u2013678 (2020).","DOI":"10.1080\/22221751.2020.1852892"},{"key":"2021010611101385000_2021.01.03.21249180v2.36","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2008-3"},{"key":"2021010611101385000_2021.01.03.21249180v2.37","doi-asserted-by":"crossref","unstructured":"Burbelo, P.D. , Ching, K.H. , Klimavicz, C.M. & Iadarola, M.J. Antibody profiling by Luciferase Immunoprecipitation Systems (LIPS). J Vis Exp (JoVE) 32(2009).","DOI":"10.3791\/1549"},{"key":"2021010611101385000_2021.01.03.21249180v2.38","unstructured":"Roweis, S. EM Algorithms for PCA and Sensible PCA. (1997)."},{"key":"2021010611101385000_2021.01.03.21249180v2.39","doi-asserted-by":"crossref","unstructured":"Stacklies W. , Redestig H. , Scholz M. , Walther D. & J., S. Methods \u2013 a Bioconductor package providing PCA methods for incomplete data. (Bioinformatics, 2007). https:\/\/bioconductor.org\/packages\/release\/bioc\/html\/pcaMethods.html.","DOI":"10.1093\/bioinformatics\/btm069"},{"key":"2021010611101385000_2021.01.03.21249180v2.40","unstructured":"L\u00ea, S. , Josse, J. & Husson, F. FactoMineR: An R Package for Multivariate Analysis. (2008). http:\/\/www.jstatsoft.org\/v25\/i01\/"},{"key":"2021010611101385000_2021.01.03.21249180v2.41","unstructured":"R project. https:\/\/cran.rproject.org\/web\/packages\/factoextra\/index.html"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2021.01.03.21249180","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T14:02:26Z","timestamp":1768485746000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2021.01.03.21249180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,4]]},"references-count":41,"URL":"https:\/\/doi.org\/10.1101\/2021.01.03.21249180","relation":{},"subject":[],"published":{"date-parts":[[2021,1,4]]},"subtype":"preprint"}}